Lifetime Risk of Venous Thromboembolism in Two Cohort Studies.

[1]  N. Roetker,et al.  Prospective study of sickle cell trait and venous thromboembolism incidence , 2015, Journal of thrombosis and haemostasis : JTH.

[2]  G. Raskob,et al.  Thrombosis: a major contributor to global disease burden. , 2014, Thrombosis research.

[3]  G. Raskob,et al.  Thrombosis: A Major Contributor to Global Disease Burden , 2014, Seminars in Thrombosis & Hemostasis.

[4]  A. Folsom,et al.  Racial and Regional Differences in Venous Thromboembolism in the United States in 3 Cohorts , 2014, Circulation.

[5]  G. Raskob,et al.  ISTH Steering Committee for World Thrombosis Day The members of the ISTH Steering Committee for World Thrombosis Day , 2014 .

[6]  Xuan Cai,et al.  Lifetime risk for heart failure among white and black Americans: cardiovascular lifetime risk pooling project. , 2013, Journal of the American College of Cardiology.

[7]  Steven Woloshin,et al.  Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. , 2010, Archives of internal medicine.

[8]  Jodi B Segal,et al.  Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. , 2009, JAMA.

[9]  S. Rathbun.  Cardiology patient pages. The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism. , 2009, Circulation.

[10]  A. Folsom,et al.  ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) , 2007, Journal of thrombosis and haemostasis : JTH.

[11]  Melania Pintilie,et al.  Analysing and interpreting competing risk data , 2007, Statistics in medicine.

[12]  P. Wolf,et al.  The lifetime risk of stroke: estimates from the Framingham Study. , 2006, Stroke.

[13]  R. White,et al.  Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996 , 2005, Thrombosis and Haemostasis.

[14]  D. Levy,et al.  Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.

[15]  T. McLoud,et al.  Trends in Thoracic Radiology Over a Decade at a Large Academic Medical Center , 2004, Journal of thoracic imaging.

[16]  Paul Enright,et al.  Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. , 2004, The American journal of medicine.

[17]  Elizabeth Waters,et al.  A glossary for evidence based public health , 2004, Journal of Epidemiology and Community Health.

[18]  J. Murabito,et al.  Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study , 2002, Circulation.

[19]  Jennifer M. Fortin,et al.  Identifying patient preferences for communicating risk estimates: A descriptive pilot study , 2001, BMC Medical Informatics Decis. Mak..

[20]  R B D'Agostino,et al.  Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. , 2000, Statistics in medicine.

[21]  P. Sasieni,et al.  Standardized lifetime risk. , 1999, American journal of epidemiology.

[22]  Enrique Sanchez-Delgado,et al.  Lifetime risk of developing coronary heart disease , 1999, The Lancet.

[23]  R. White,et al.  Incidence of Idiopathic Deep Venous Thrombosis and Secondary Thromboembolism among Ethnic Groups in California , 1998, Annals of Internal Medicine.

[24]  A. Folsom,et al.  Differences between respondents and nonrespondents in a multicenter community-based study vary by gender and ethnicity , 1996 .

[25]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[26]  A. Folsom,et al.  Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1996, Journal of clinical epidemiology.

[27]  R. Bertina,et al.  Laboratory Diagnosis of APC-Resistance: A Critical Evaluation of the Test and the Development of Diagnostic Criteria , 1994, Thrombosis and Haemostasis.

[28]  L. Fried,et al.  Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. , 1993, Annals of epidemiology.

[29]  W D Flanders,et al.  The lifetime risk of developing breast cancer. , 1993, Journal of the National Cancer Institute.

[30]  Aric Invest.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .

[31]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.